Association of Slopes of Estimated Glomerular Filtration Rate With Post–End-Stage Renal Disease Mortality in Patients With Advanced Chronic Kidney Disease Transitioning to Dialysis

Mayo Clinic Proceedings

Volumn 91, Issue 2, 2016, Pages 196-207

  Sumida, Keiichi ^a   Molnar, Miklos Z ^a   Potukuchi, Praveen K ^a   Thomas, Fridtjof ^a   Lu, Jun Ling ^a   Jing, Jennie ^b   Ravel, Vanessa A ^b   Soohoo, Melissa ^b   Rhee, Connie M ^b   Streja, Elani ^b   Kalantar Zadeh, Kamyar ^b,c   Kovesdy, Csaba P ^a,d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL PARAMETERS; CARDIOVASCULAR DISEASES; DISEASE COURSE; HEMODIALYSIS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFECTION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84979030187     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2015.10.026     Document Type: Article

References (37)

1. 1 United States Renal Data System. 2014 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. 2014, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
2. 2 Robinson, B.M., Zhang, J., Morgenstern, H., et al. Worldwide, mortality risk is high soon after initiation of hemodialysis. Kidney Int 85:1 (2014), 158–165.
3. 3 Bradbury, B.D., Fissell, R.B., Albert, J.M., et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2:1 (2007), 89–99.
4. 4 Rhee, C.M., Kalantar-Zadeh, K., Transition to dialysis: controversies in its timing and modality. [published correction appears in Semin Dial. 2014;27(1):60] Semin Dial 26:6 (2013), 641–643.
5. 5 Turin, T.C., Coresh, J., Tonelli, M., et al. Short-term change in kidney function and risk of end-stage renal disease. Nephrol Dial Transplant 27:10 (2012), 3835–3843.
6. 6 Coresh, J., Turin, T.C., Matsushita, K., et al., CKD Prognosis Consortium. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311:24 (2014), 2518–2531.
7. 7 Matsushita, K., Selvin, E., Bash, L.D., Franceschini, N., Astor, B.C., Coresh, J., Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 20:12 (2009), 2617–2624.
8. 8 Shlipak, M.G., Katz, R., Kestenbaum, B., et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 20:12 (2009), 2625–2630.
9. 9 Rifkin, D.E., Shlipak, M.G., Katz, R., et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168:20 (2008), 2212–2218.
10. 10 Lambers Heerspink, H.J., Weldegiorgis, M., Inker, L.A., et al. Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT). Am J Kidney Dis 63:2 (2014), 244–250.
11. 11 Al-Aly, Z., Zeringue, A., Fu, J., et al. Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21:11 (2010), 1961–1969.
12. 12 Perkins, R.M., Bucaloiu, I.D., Kirchner, H.L., Ashouian, N., Hartle, J.E., Yahya, T., GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 6:8 (2011), 1879–1886.
13. 13 Turin, T.C., Coresh, J., Tonelli, M., et al. One-year change in kidney function is associated with an increased mortality risk. Am J Nephrol 36:1 (2012), 41–49.
14. 14 Turin, T.C., Coresh, J., Tonelli, M., et al. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int 83:4 (2013), 684–691.
15. 15 O'Hare, A.M., Batten, A., Burrows, N.R., et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis 59:4 (2012), 513–522.
16. 16 US Department of Veterans Affairs Health Services Research and Development Service, VA Information Resource Center. VIReC Resource Guide: VA Corporate Data Warehouse. 2012, VA Information Resource Center, Hines, IL.
17. 17 US Department of Veterans Affairs Health Services Research and Development Service, VA Information Resource Center. VIReC Research User Guide: VHA Decision Support System Clinical National Data Extracts. 2nd ed., 2009, VA Information Resource Center, Hines, IL.
18. 18 US Department of Veterans Affairs Health Services Research and Development Service, VA Information Resource Center. VIReC Research User Guide: VHA Pharmacy Prescription Data. 2nd ed., 2008, VA Information Resource Center, Hines, IL.
19. 19 US Department of Veterans Affairs Health Services Research and Development Service, VA Information Resource Center. VIReC Research User Guide: VHA Medical SAS Inpatient Datasets FY2006-2007. 2007, VA Information Resource Center, Hines, IL.
20. 20 Deyo, R.A., Cherkin, D.C., Ciol, M.A., Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:6 (1992), 613–619.
21. 21 Levey, A.S., Stevens, L.A., Schmid, C.H., et al., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. [published correction appears in Ann Intern Med. 2011;155(6):408] Ann Intern Med 150:9 (2009), 604–612.
22. 22 Levin, A., Stevens, P.E., Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85:1 (2014), 49–61.
23. 23 Fine, J.P., Gray, R.J., A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999), 496–509.
24. 24 Onuigbo, M.A., Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD. Ren Fail 32:8 (2010), 954–958.
25. 25 Onuigbo, M., Agbasi, N., Syndrome of rapid onset ESRD accounted for high hemodialysis catheter use—results of a 13-year Mayo Clinic incident hemodialysis study. Ren Fail 37:9 (2015), 1486–1491.
26. 26 Manjunath, G., Tighiouart, H., Ibrahim, H., et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41:1 (2003), 47–55.
27. 27 Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:17 (2003), 2154–2169.
28. 28 Kottgen, A., Russell, S.D., Loehr, L.R., et al. Reduced kidney function as a risk factor for incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. J Am Soc Nephrol 18:4 (2007), 1307–1315.
29. 29 Shlipak, M.G., Stehman-Breen, C., Fried, L.F., et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 43:5 (2004), 861–867.
30. 30 Odden, M.C., Chertow, G.M., Fried, L.F., et al., HABC Study. Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol 164:12 (2006), 1180–1189.
31. 31 Kovesdy, C.P., George, S.M., Anderson, J.E., Kalantar-Zadeh, K., Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr 90:2 (2009), 407–414.
32. 32 Lee, P.S., Waxman, A.B., Cotich, K.L., Chung, S.W., Perrella, M.A., Stossel, T.P., Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med 35:3 (2007), 849–855.
33. 33 Goetzl, E.J., Lee, H., Azuma, T., Stossel, T.P., Turck, C.W., Karliner, J.S., Gelsolin binding and cellular presentation of lysophosphatidic acid. J Biol Chem 275:19 (2000), 14573–14578.
34. 34 Bucki, R., Georges, P.C., Espinassous, Q., et al. Inactivation of endotoxin by human plasma gelsolin. Biochemistry 44:28 (2005), 9590–9597.
35. 35 Osborn, T.M., Dahlgren, C., Hartwig, J.H., Stossel, T.P., Modifications of cellular responses to lysophosphatidic acid and platelet-activating factor by plasma gelsolin. Am J Physiol Cell Physiol 292:4 (2007), C1323–C1330.
36. 36 Lee, P.S., Sampath, K., Karumanchi, S.A., et al. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 20:5 (2009), 1140–1148.
37. 37 Kovesdy, C.P., Kalantar-Zadeh, K., Why is protein-energy wasting associated with mortality in chronic kidney disease?. Semin Nephrol 29:1 (2009), 3–14.